DARPA Announces New Anesthetics for Battlefield Care (ABC) Development Program
- Japan Second Round of Nuclear Contaminated Water Discharge Set to Commence
- Johns Hopkins University: Early Plasma Therapy Reduces Long COVID Risk
- Ketogenic Diet Linked to Heart Diseases and Cancers
- TROP2 ADC for Breast Cancer Succeeded In Phase III Clinical Trials
- Lead Poisoning’s More Serious Impacts on Health and IQ
- Startling Link Between Alcohol and Alzheimer’s Disease
DARPA Announces New Anesthetics for Battlefield Care (ABC) Development Program
- Nearly 300 People Food Poisoning in Japanese 130-Year Restaurant
- FDA’s First Potential TIL Therapy Review Delayed: How to Understand FDA’s “Resource Constraints”?
- A Chinese Doctor Accused of Accepting Bribes Totaling US$166 Million
- Nuclear contaminated water: Japanese government paid bribes and corrected the IAEA report
- Top 20 Companies of Instruments and Medical Equipment In The World
- The first DMD gene therapy SRP-9001 may cost 4 million US dollars
- How long can the patient live after heart stent surgery?
DARPA Announces New Anesthetics for Battlefield Care (ABC) Development Program.
DARPA has announced its new Agents of Battlefield Care (ABC) program, which aims to develop a new combat anesthetic that can be applied to the wounded on the battlefield without requiring specialized medical training or complex monitoring instruments.
Like many everyday things, we take narcotics for granted so much that it’s hard to imagine a time when they didn’t exist. Anesthetics and the technologies that support them have made enormous life-saving advances since they were first developed in the 1840s, but not in the field of battlefield anesthetics, which are still not much better than a shot of morphine.
There are two reasons for this. The first reason is that anesthetics are not simply painkillers. They are a complex cocktail of drugs designed to perform a number of functions, including calming the patient, reducing pain perception, immobilizing the body or inducing a general state of anesthesia. A
dditionally, administering anesthesia requires specialist monitoring of the patient and providing support in the form of various gases and other mechanisms to stabilize breathing, keep oxygen levels in the green zone, and maintain heart function.
Another reason is that although anesthetics have been used hundreds of millions of times, no one really understands how they work. Doctors know how to use anesthetics, but they don’t know the mechanisms behind them.
DARPA’s goal in Project ABC is to solicit ideas on how to create a simpler, easier-to-apply battlefield anesthetic by looking at the problem at its fundamentals.
This new approach involves studying the mechanisms of anesthetics from the anatomical to the molecular level to untangle the “why” and develop a way to eliminate pain, allowing life-saving treatments to be administered as close as possible to the point of injury on the battlefield, Without the need for hospital-grade equipment and specialists or dangerous physiological side effects.
ABC program manager Michael Feasel said: “Battlefield care anesthesia is taking the risk out of a problem that, while targeting the U.S. Department of Defense, is disruptive to all of medicine.
It can make everything from rural emergency services to air medical services, First responders all the way to level one trauma centers benefit.
The program is designed to support the earlier adoption of life-saving interventions, closer to the point of injury, leading to better outcomes for all patients, whether combatants or civilians.”
DARPA Announces New Anesthetics for Battlefield Care (ABC) Development Program
(source:internet, reference only)
Disclaimer of medicaltrend.org
